- Home
- BRC vs IMVT Comparison
BRC vs IMVT Comparison
Compare BRC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRC
- IMVT
- Stock Information
- Founded
- BRC 1914
- IMVT N/A
- Country
- BRC United States
- IMVT United States
- Employees
- BRC N/A
- IMVT N/A
- Industry
- BRC Miscellaneous manufacturing industries
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRC Consumer Discretionary
- IMVT Health Care
- Exchange
- BRC Nasdaq
- IMVT Nasdaq
- Market Cap
- BRC 3.4B
- IMVT 3.4B
- IPO Year
- BRC 1984
- IMVT N/A
- Fundamental
- Price
- BRC $70.68
- IMVT $17.09
- Analyst Decision
- BRC
- IMVT Strong Buy
- Analyst Count
- BRC 0
- IMVT 11
- Target Price
- BRC N/A
- IMVT $44.13
- AVG Volume (30 Days)
- BRC 317.2K
- IMVT 1.8M
- Earning Date
- BRC 05-21-2025
- IMVT 02-06-2025
- Dividend Yield
- BRC 1.36%
- IMVT N/A
- EPS Growth
- BRC 4.86
- IMVT N/A
- EPS
- BRC 3.99
- IMVT N/A
- Revenue
- BRC $1,420,526,000.00
- IMVT N/A
- Revenue This Year
- BRC $13.46
- IMVT $108.88
- Revenue Next Year
- BRC $4.07
- IMVT N/A
- P/E Ratio
- BRC $17.70
- IMVT N/A
- Revenue Growth
- BRC 6.20
- IMVT N/A
- 52 Week Low
- BRC $57.89
- IMVT $16.72
- 52 Week High
- BRC $77.68
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- BRC 46.66
- IMVT 35.78
- Support Level
- BRC $70.36
- IMVT $17.49
- Resistance Level
- BRC $72.27
- IMVT $18.96
- Average True Range (ATR)
- BRC 1.44
- IMVT 1.24
- MACD
- BRC 0.09
- IMVT -0.09
- Stochastic Oscillator
- BRC 52.81
- IMVT 9.95
About BRC Brady Corporation
Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).